ATSA Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Azacitidine (100mg)
Overview ATSA Injection
Myelodysplastic syndrome (MDS), in its various forms affecting adults, is treated with ATSA Injection. This medication may also address other conditions as directed by a physician. Administered intravenously under strict medical supervision, the dosage and frequency of ATSA Injection are determined individually by your doctor, contingent upon your specific condition and potentially adjusted over time. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdosage can result in severe adverse effects. While therapeutic benefits might not be immediately apparent—taking several weeks or months—discontinuation should only occur upon your doctor's instruction. Common side effects include injection site inflammation (pain, swelling, redness), nausea, vomiting, and fatigue. Report any concerning symptoms to your physician; mitigation strategies may be available. Vaccination during treatment requires prior physician consultation. Regular blood tests monitoring blood cell counts, as well as liver, kidney, and cardiac function, are necessary. Prior to commencing treatment, disclose any existing liver or kidney conditions, and all medications, especially those combating infections, to your doctor. Interactions with other medications are possible; comprehensive medication disclosure is essential. This injection is contraindicated during pregnancy and breastfeeding.
Uses of ATSA Injection
Myelodysplastic syndromes: Blood cancer therapies
Major Benefits of ATSA Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of ATSA Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use ATSA Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How ATSA Injection works:
Leukemia treatment with ATSA Injection involves targeting the cancerous cells' genetic machinery (DNA and RNA), halting their replication. This mechanism leads to the death of malignant cells and facilitates healthy blood cell development within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside ATSA Injection presents an unknown safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering ATSA Injection during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering ATSA Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering ATSA Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, potentially impairing driving skills.
KidneyCAUTION
Exercise caution when administering ATSA Injection to individuals with impaired renal function. Dosage modification of ATSA Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Administering ATSA Injection requires careful consideration in individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. ATSA Injection is contraindicated in patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take ATSA Injection :
NA
Facts to Know About ATSA Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | Metabolic inhibitors |
3,018 People bought this recently